Cargando…

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme

AIMS/HYPOTHESIS: The aim of our study was to identify subgroups of patients attending the Scottish Diabetic Retinopathy Screening (DRS) programme who might safely move from annual to two yearly retinopathy screening. METHODS: This was a retrospective cohort study of screening data from the DRS progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Looker, H. C., Nyangoma, S. O., Cromie, D. T., Olson, J. A., Leese, G. P., Philip, S., Black, M. W., Doig, J., Lee, N., Briggs, A., Hothersall, E. J., Morris, A. D., Lindsay, R. S., McKnight, J. A., Pearson, D. W. M., Sattar, N. A., Wild, S. H., McKeigue, P., Colhoun, H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699707/
https://www.ncbi.nlm.nih.gov/pubmed/23689796
http://dx.doi.org/10.1007/s00125-013-2928-7
_version_ 1782275442804260864
author Looker, H. C.
Nyangoma, S. O.
Cromie, D. T.
Olson, J. A.
Leese, G. P.
Philip, S.
Black, M. W.
Doig, J.
Lee, N.
Briggs, A.
Hothersall, E. J.
Morris, A. D.
Lindsay, R. S.
McKnight, J. A.
Pearson, D. W. M.
Sattar, N. A.
Wild, S. H.
McKeigue, P.
Colhoun, H. M.
author_facet Looker, H. C.
Nyangoma, S. O.
Cromie, D. T.
Olson, J. A.
Leese, G. P.
Philip, S.
Black, M. W.
Doig, J.
Lee, N.
Briggs, A.
Hothersall, E. J.
Morris, A. D.
Lindsay, R. S.
McKnight, J. A.
Pearson, D. W. M.
Sattar, N. A.
Wild, S. H.
McKeigue, P.
Colhoun, H. M.
author_sort Looker, H. C.
collection PubMed
description AIMS/HYPOTHESIS: The aim of our study was to identify subgroups of patients attending the Scottish Diabetic Retinopathy Screening (DRS) programme who might safely move from annual to two yearly retinopathy screening. METHODS: This was a retrospective cohort study of screening data from the DRS programme collected between 2005 and 2011 for people aged ≥12 years with type 1 or type 2 diabetes in Scotland. We used hidden Markov models to calculate the probabilities of transitions to referable diabetic retinopathy (referable background or proliferative retinopathy) or referable maculopathy. RESULTS: The study included 155,114 individuals with no referable diabetic retinopathy or maculopathy at their first DRS examination and with one or more further DRS examinations. There were 11,275 incident cases of referable diabetic eye disease (9,204 referable maculopathy, 2,071 referable background or proliferative retinopathy). The observed transitions to referable background or proliferative retinopathy were lower for people with no visible retinopathy vs mild background retinopathy at their prior examination (respectively, 1.2% vs 8.1% for type 1 diabetes and 0.6% vs 5.1% for type 2 diabetes). The lowest probability for transitioning to referable background or proliferative retinopathy was among people with two consecutive screens showing no visible retinopathy, where the probability was <0.3% for type 1 and <0.2% for type 2 diabetes at 2 years. CONCLUSIONS/INTERPRETATION: Transition rates to referable diabetic eye disease were lowest among people with type 2 diabetes and two consecutive screens showing no visible retinopathy. If such people had been offered two yearly screening the DRS service would have needed to screen 40% fewer people in 2009. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-013-2928-7) contains peer reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-3699707
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-36997072013-08-05 Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme Looker, H. C. Nyangoma, S. O. Cromie, D. T. Olson, J. A. Leese, G. P. Philip, S. Black, M. W. Doig, J. Lee, N. Briggs, A. Hothersall, E. J. Morris, A. D. Lindsay, R. S. McKnight, J. A. Pearson, D. W. M. Sattar, N. A. Wild, S. H. McKeigue, P. Colhoun, H. M. Diabetologia Article AIMS/HYPOTHESIS: The aim of our study was to identify subgroups of patients attending the Scottish Diabetic Retinopathy Screening (DRS) programme who might safely move from annual to two yearly retinopathy screening. METHODS: This was a retrospective cohort study of screening data from the DRS programme collected between 2005 and 2011 for people aged ≥12 years with type 1 or type 2 diabetes in Scotland. We used hidden Markov models to calculate the probabilities of transitions to referable diabetic retinopathy (referable background or proliferative retinopathy) or referable maculopathy. RESULTS: The study included 155,114 individuals with no referable diabetic retinopathy or maculopathy at their first DRS examination and with one or more further DRS examinations. There were 11,275 incident cases of referable diabetic eye disease (9,204 referable maculopathy, 2,071 referable background or proliferative retinopathy). The observed transitions to referable background or proliferative retinopathy were lower for people with no visible retinopathy vs mild background retinopathy at their prior examination (respectively, 1.2% vs 8.1% for type 1 diabetes and 0.6% vs 5.1% for type 2 diabetes). The lowest probability for transitioning to referable background or proliferative retinopathy was among people with two consecutive screens showing no visible retinopathy, where the probability was <0.3% for type 1 and <0.2% for type 2 diabetes at 2 years. CONCLUSIONS/INTERPRETATION: Transition rates to referable diabetic eye disease were lowest among people with type 2 diabetes and two consecutive screens showing no visible retinopathy. If such people had been offered two yearly screening the DRS service would have needed to screen 40% fewer people in 2009. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-013-2928-7) contains peer reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2013-05-21 2013 /pmc/articles/PMC3699707/ /pubmed/23689796 http://dx.doi.org/10.1007/s00125-013-2928-7 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Article
Looker, H. C.
Nyangoma, S. O.
Cromie, D. T.
Olson, J. A.
Leese, G. P.
Philip, S.
Black, M. W.
Doig, J.
Lee, N.
Briggs, A.
Hothersall, E. J.
Morris, A. D.
Lindsay, R. S.
McKnight, J. A.
Pearson, D. W. M.
Sattar, N. A.
Wild, S. H.
McKeigue, P.
Colhoun, H. M.
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
title Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
title_full Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
title_fullStr Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
title_full_unstemmed Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
title_short Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
title_sort predicted impact of extending the screening interval for diabetic retinopathy: the scottish diabetic retinopathy screening programme
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699707/
https://www.ncbi.nlm.nih.gov/pubmed/23689796
http://dx.doi.org/10.1007/s00125-013-2928-7
work_keys_str_mv AT lookerhc predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT nyangomaso predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT cromiedt predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT olsonja predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT leesegp predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT philips predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT blackmw predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT doigj predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT leen predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT briggsa predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT hothersallej predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT morrisad predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT lindsayrs predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT mcknightja predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT pearsondwm predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT sattarna predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT wildsh predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT mckeiguep predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT colhounhm predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme
AT predictedimpactofextendingthescreeningintervalfordiabeticretinopathythescottishdiabeticretinopathyscreeningprogramme